Viscogliosi Brothers Acquisition, a blank check company targeting the North American and European neuro-musculoskeletal industry, raised $75 million by offering 7.5 million units at $10. Each unit consists of one share of common stock and one-half of a warrant, exercisable at $11.50.
The SPAC is led by CEO and Chairman John Viscogliosi, a founding member and Principal of single-family office Viscogliosi Bros and the former CEO of Centinel Spine, and CFO Steve Ward, the CFO and COO of Viscogliosi and former CFO of Paradigm Spine. Viscogliosi Brothers Acquisition plans to leverage management's experience and target the neuro-musculoskeletal (NMS) industry, specifically within the implantable devices, service, regenerative medicine, and contract manufacturing sectors.
Viscogliosi Brothers Acquisition plans to list on the Nasdaq under the symbol VBOCU. Raymond James acted as sole bookrunner on the deal.
